|

Radial Access Data in Vascular Interventions Registry

RECRUITINGSponsored by Mersin Medicalpark Hastanesi
Actively Recruiting
SponsorMersin Medicalpark Hastanesi
Started2026-05-15
Est. completion2030-12-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The RADIUS study is a prospective observational registry designed to collect real-world data regarding radial and ulnar artery access in percutaneous vascular interventions. The study aims to evaluate procedural characteristics, access-site complications, procedural success, and short-term clinical outcomes associated with transradial and transulnar vascular access. Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access at Mersin Medical Park Hospital will be consecutively enrolled. Demographic, clinical, angiographic, procedural, and post-procedural data will be prospectively collected and analyzed. The study was initially designed as a single-center registry; however, following Institutional Review Board (IRB) approval, expansion into a multicenter registry with participating centers is planned. This study is observational in nature and does not involve any experimental treatment, device, or intervention beyond standard clinical care.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age ≥18 years
* Patients undergoing routine percutaneous vascular interventions via radial or ulnar artery access
* Ability to provide informed consent

Exclusion Criteria:

* Age \<18 years
* Procedures performed without radial or ulnar artery access
* Incomplete procedural or clinical data
* Refusal to participate in the registry

Conditions6

Coronary Artery DiseaseHeart DiseasePeripheral Arterial DiseaseRadial Artery OcclusionRadial Artery SpasmVascular Access Complications

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.